Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 October 2005, Vol. 106, No. 7, pp. 2491-2497.
Prepublished online as a Blood First Edition Paper on June 9, 2005; DOI 10.1182/blood-2005-03-1175.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-03-1175v1
106/7/2491    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kodama, K.
Right arrow Articles by Cerroni, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kodama, K.
Right arrow Articles by Cerroni, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted March 23, 2005
Accepted May 25, 2005

Primary cutaneous large B-cell lymphomas. Clinicopathologic features, classification, and prognostic factors in a large series of patients.

Kazuo Kodama, Cesare Massone, Andreas Chott, Dieter Metze, Helmut Kerl, and Lorenzo Cerroni*

Departments of Dermatology, Medical University, Graz, Austria; Hokkaido University, Sapporo, Japan
Departments of Dermatology, Medical University, Graz, Austria
Department of Pathology, Medical University of Vienna, Vienna, Austria
University of Munster, Munster, Germany

* Corresponding author; email: lorenzo.cerroni{at}meduni-graz.at.

In the new World Health Organization/European Organization for Research and Treatment of Cancer (WHO/EORTC) classification of cutaneous lymphomas, large B-cell lymphomas (LBCLs) are divided into 3 groups: LBCL, leg-type (LBCLLT); follicle center lymphoma, diffuse type (FCLDT); LBCL, others (LBCLO). We studied a large number of primary cutaneous LBCLs in order to test the validity of the classification, and to identify prognostic factors for these patients. Ninety-three cases of primary cutaneous LBCL were analyzed for clinicopathologic features, expression of several markers including Bcl-2, Bcl-6, MUM-1, and FOX-P1, in-situ-hybridization for Epstein-Barr virus, and molecular analyses of IgH gene rearrangement and of Borrelia burgdorferi and Human herpesvirus 8 DNA. Patients were classified into the following categories: FCLDT: 44 cases; LBCLLT: 40 cases. LBCLO: 9 cases. Statistical analyses showed that the groups of LBCLLT and FCLDT were clearly distinct in terms of clinicopathologic features and survival. The group of LBCLO had features in-between those of LBCLLT and FCLDT. Our study shows that accurate morphologic and phenotypic analyses allow to stratify most patients into the prognostically different categories of LBCLLT and FCLDT. The definition of a third category of LBCLO requires further studies to clarify whether these cases show indeed distinct clinicopathologic features.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
P. J. Brown, S. L. Ashe, E. Leich, C. Burek, S. Barrans, J. A. Fenton, A. S. Jack, K. Pulford, A. Rosenwald, and A. H. Banham
Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL
Blood, March 1, 2008; 111(5): 2816 - 2824.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
N. J. Senff, J. J. Hoefnagel, K. J. Neelis, M. H. Vermeer, E. M. Noordijk, R. Willemze, and for the Dutch Cutaneous Lymphoma Group
Results of Radiotherapy in 153 Primary Cutaneous B-Cell Lymphomas Classified According to the WHO-EORTC Classification
Arch Dermatol, December 1, 2007; 143(12): 1520 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
F. Grange, M. Beylot-Barry, P. Courville, E. Maubec, M. Bagot, B. Vergier, P. Souteyrand, L. Machet, S. Dalac, E. Esteve, et al.
Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Clinicopathologic Features and Prognostic Analysis in 60 Cases
Arch Dermatol, September 1, 2007; 143(9): 1144 - 1150.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. J. Senff, J. J. Hoefnagel, P. M. Jansen, M. H. Vermeer, J. van Baarlen, W. A. Blokx, M. R. Canninga-van Dijk, M.-L. Geerts, K. M. Hebeda, P. M. Kluin, et al.
Reclassification of 300 Primary Cutaneous B-Cell Lymphomas According to the New WHO-EORTC Classification for Cutaneous Lymphomas: Comparison With Previous Classifications and Identification of Prognostic Markers
J. Clin. Oncol., April 20, 2007; 25(12): 1581 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
Persistent Violaceous Papules on the Ears--Diagnosis
Arch Dermatol, March 1, 2007; 143(3): 417 - 422.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L Cerroni
Lymphoproliferative lesions of the skin.
J. Clin. Pathol., August 1, 2006; 59(8): 813 - 826.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020